Directory
>
Sushmita Chanda Dabt
Sushmita Chanda Dabt
Chief Development Officer | Aligos Therapeutics
San Francisco, California, United States
Sushmita Chanda Dabt
Summary
Sushmita Chanda Dabt is an accomplished executive with over 20 years of experience in the pharmaceutical industry, specializing in drug discovery and development. Currently serving as the Chief Development Officer at Aligos Therapeutics, she has a strong background in translational safety sciences and preclinical development. Sushmita holds a Ph.D. in Toxicology and Pharmacology and has completed postdoctoral training at the University of North Carolina. Her expertise encompasses a wide range of areas including biochemistry, immunology, and clinical pharmacology, making her a valuable asset in the biopharmaceutical sector. Her leadership roles have consistently focused on advancing therapeutic innovations, particularly in oncology and infectious diseases. Sushmita's commitment to research and development is complemented by her strategic insight into regulatory affairs and technology transfer. She is passionate about pioneering new treatments that can significantly impact patient care.
Sushmita Chanda Dabt
Work Experience
Chief Development Officer at
Aligos Therapeutics
March 2024 - Present
EVP, Translational Safety Sciences at
Aligos Therapeutics
August 2018 - March 2024
VP, Preclinical Development at
Alios Biopharma A Johnson And Johnson
February 2010 - July 2018
Sr. Director, Head Non Clinical Safety at
Roche Palo Alto LLC
January 2009 - January 2010
Director, Toxicology, Non Clinical Safety at
Roche Palo Alto LLC
January 2000 - April 2009
Toxicologist at
SUGEN SRL
January 1998 - January 2000
Sushmita Chanda Dabt
Education
University of North Carolina at Chapel Hill, Post Doctoral Training
January 1995 - January 1998
University of Louisiana at Monroe, Ph.D.
January 1990 - January 1995
Frequently Asked Questions about Sushmita Chanda Dabt
What is Sushmita Chanda Dabt email address?
Sushmita Chanda Dabt's primary email address is *******@aligos.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sushmita Chanda Dabt work for?
Sushmita Chanda Dabt is a Chief Development Officer at Aligos Therapeutics, a company specializing in Biological products, except diagnostic.
Where Sushmita Chanda Dabt graduated from?
Sushmita Chanda Dabt holds a degree in Toxicology from University of North Carolina at Chapel Hill.
How can I directly contact Sushmita Chanda Dabt?
To contact Sushmita Chanda Dabt directly, you can use the email address *******@aligos.com. Complete contact information is available upon registration with Muraena.
Who is Sushmita Chanda Dabt?
Sushmita Chanda Dabt is an accomplished executive with over 20 years of experience in the pharmaceutical industry, specializing in drug discovery and development. Currently serving as the Chief Development Officer at Aligos Therapeutics, she has a strong background in translational safety sciences and preclinical development. Sushmita holds a Ph.D. in Toxicology and Pharmacology and has completed postdoctoral training at the University of North Carolina. Her expertise encompasses a wide range of areas including biochemistry, immunology, and clinical pharmacology, making her a valuable asset in the biopharmaceutical sector. Her leadership roles have consistently focused on advancing therapeutic innovations, particularly in oncology and infectious diseases. Sushmita's commitment to research and development is complemented by her strategic insight into regulatory affairs and technology transfer. She is passionate about pioneering new treatments that can significantly impact patient care.
Sushmita`s contact details
*******@aligos.com
Colleagues
Executive Director
Executive Director, DMPK
Chief Executive Officer
Chief Scientific Officer
Vice President
Executive Director Information Technology
Executive Vice President
Executive Director, Head of Clinical Operations
Co-Founder & Advisor
Executive Director